trending Market Intelligence /marketintelligence/en/news-insights/trending/nfxwtlajnuvq4ciwoiqh5g2 content esgSubNav
In This List

Atossa Genetics to raise $13.4M via rights offering

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Atossa Genetics to raise $13.4M via rights offering

Seattle, Wash.-based Atossa Genetics Inc. said it expects to raise $13.4 million via a rights offering that expired May 24.

The rights offering was priced at $1,000 per unit, and allowed eligible shareholders to receive a series B preferred stock and warrants to buy 284 common stock of the company at $4.05 each.

The series B stock is immediately convertible into 284 common shares of the company.

Atossa engaged Maxim Group LLC as dealer-manager in the offering.